AGIOS PHARMACEUTICALS, INC. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Agios Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Agios Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending September 30, 2024 was $4.68M, a 2.95% increase year-over-year.
  • Agios Pharmaceuticals, Inc. Operating Lease, Payments for the twelve months ending September 30, 2024 was $18.6M, a 2.95% increase year-over-year.
  • Agios Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $18.2M, a 6.66% increase from 2022.
  • Agios Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $17M, a 18.2% increase from 2021.
  • Agios Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $14.4M, a 0.09% decline from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $18.2M +$1.14M +6.66% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 $17M +$2.62M +18.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 $14.4M -$13K -0.09% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $14.4M +$1.62M +12.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $12.8M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.